Stock BRG BORREGAARD ASA
Add to a list
To use this feature you must be a member
Log inSign up

Financials Borregaard ASA

Equities

BRG

NO0010657505

Specialty Chemicals

Market Closed - Oslo Bors
Other stock markets
 10:45:00 2024-04-26 am EDT 		5-day change 1st Jan Change
187.8 NOK -1.16% Intraday chart for Borregaard ASA -3.00% +9.57%
Apr. 24 Borregaard ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 24 Transcript : Borregaard ASA, Q1 2024 Earnings Call, Apr 24, 2024

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 9,465 14,125 22,108 15,138 17,064 18,731 - -
Enterprise Value (EV) 1 11,345 15,919 23,525 16,974 18,855 20,946 20,537 20,604
P/E ratio 22.8 x 32.5 x 31.9 x 17 x 19.7 x 20.3 x 17.3 x 16.4 x
Yield 2.42% 1.76% 1.24% 2.14% 2.19% 2.58% 2.79% 2.73%
Capitalization / Revenue 1.87 x 2.65 x 3.81 x 2.2 x 2.39 x 2.36 x 2.21 x 2.18 x
EV / Revenue 2.24 x 2.99 x 4.05 x 2.47 x 2.64 x 2.64 x 2.43 x 2.4 x
EV / EBITDA 11.3 x 14.1 x 17.1 x 10.3 x 10.6 x 11.2 x 9.84 x 9.47 x
EV / FCF 99.5 x 41.6 x 32.2 x 62.6 x 21 x 47.3 x 31.3 x 23.7 x
FCF Yield 1% 2.41% 3.1% 1.6% 4.75% 2.11% 3.19% 4.23%
Price to Book 2.87 x 3.87 x 5.26 x 3.44 x 3.51 x 3.57 x 3.17 x 2.85 x
Nbr of stocks (in thousands) 99,633 99,615 99,585 99,594 99,556 99,739 - -
Reference price 2 95.00 141.8 222.0 152.0 171.4 187.8 187.8 187.8
Announcement Date 2/5/20 2/3/21 2/3/22 2/2/23 1/31/24 - - -
1NOK in Million2NOK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 5,063 5,328 5,805 6,881 7,132 7,941 8,469 8,600
EBITDA 1 1,007 1,132 1,372 1,643 1,781 1,863 2,087 2,175
EBIT 1 558 568 952 1,186 1,291 1,346 1,540 1,628
Operating Margin 11.02% 10.66% 16.4% 17.24% 18.1% 16.95% 18.18% 18.93%
Earnings before Tax (EBT) 1 467 496 873 1,118 1,124 1,195 1,413 1,486
Net income 1 417 436 692 892 870 987.1 1,173 1,291
Net margin 8.24% 8.18% 11.92% 12.96% 12.2% 12.43% 13.85% 15.01%
EPS 2 4.170 4.360 6.950 8.950 8.710 9.232 10.83 11.44
Free Cash Flow 1 114 383 730 271 896 442.9 655.1 871
FCF margin 2.25% 7.19% 12.58% 3.94% 12.56% 5.58% 7.74% 10.13%
FCF Conversion (EBITDA) 11.32% 33.83% 53.21% 16.49% 50.31% 23.77% 31.39% 40.04%
FCF Conversion (Net income) 27.34% 87.84% 105.49% 30.38% 102.99% 44.87% 55.85% 67.48%
Dividend per Share 2 2.300 2.500 2.750 3.250 3.750 4.850 5.240 5.130
Announcement Date 2/5/20 2/3/21 2/3/22 2/2/23 1/31/24 - - -
1NOK in Million2NOK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 1,446 1,615 1,744 1,752 1,770 1,850 1,963 1,714 1,605 1,975 2,053 2,012 1,887 2,084 2,107
EBITDA 1 263 400 445 434 364 435 537 482 327 442 513.7 505.3 401.9 514 545
EBIT 1 156 291 346 321 228 320 419 360 192 308 402.5 399.8 298.9 380 410
Operating Margin 10.79% 18.02% 19.84% 18.32% 12.88% 17.3% 21.34% 21% 11.96% 15.59% 19.61% 19.88% 15.84% 18.23% 19.46%
Earnings before Tax (EBT) 1 132 277 322 309 210 292 379 318 135 261 368.6 367 266.5 364.8 404.8
Net income 1 102 217 252 239 184 231 283 237 119 200 284.2 282.9 205.6 280.8 311.3
Net margin 7.05% 13.44% 14.45% 13.64% 10.4% 12.49% 14.42% 13.83% 7.41% 10.13% 13.84% 14.06% 10.9% 13.47% 14.77%
EPS 2 1.020 2.170 2.520 2.400 1.850 2.320 2.840 2.370 1.190 2.000 2.833 2.908 2.293 2.955 3.326
Dividend per Share 2 2.750 - - - 3.250 - - - 3.750 - - - 4.300 - -
Announcement Date 2/3/22 5/3/22 7/14/22 10/21/22 2/2/23 5/2/23 7/17/23 10/24/23 1/31/24 4/24/24 - - - - -
1NOK in Million2NOK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,880 1,794 1,417 1,836 1,791 2,215 1,806 1,873
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.867 x 1.585 x 1.033 x 1.117 x 1.006 x 1.189 x 0.8655 x 0.861 x
Free Cash Flow 1 114 383 730 271 896 443 655 871
ROE (net income / shareholders' equity) 13% 12.5% 17.5% 20.7% 18.8% 19.6% 21.4% 22.7%
ROA (Net income/ Total Assets) 6.57% 6.3% 9.77% 11.7% 10.1% 10.1% 10.5% 11.2%
Assets 1 6,348 6,921 7,085 7,640 8,614 9,773 11,170 11,524
Book Value Per Share 2 33.10 36.70 42.20 44.10 48.80 52.60 59.30 65.90
Cash Flow per Share 6.970 8.890 - - - - - -
Capex 1 583 503 701 464 667 914 754 678
Capex / Sales 11.51% 9.44% 12.08% 6.74% 9.35% 11.5% 8.9% 7.88%
Announcement Date 2/5/20 2/3/21 2/3/22 2/2/23 1/31/24 - - -
1NOK in Million2NOK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Borregaard ASA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
187.8 NOK
Average target price
202.8 NOK
Spread / Average Target
+7.96%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Industrial Biotechnology Chemicals

1st Jan change Capi.
BORREGAARD ASA Stock Borregaard ASA
+9.57% 1.7B
NOVONESIS A/S Stock Novonesis A/S
+4.99% 25.92B
CATHAY BIOTECH INC. Stock Cathay Biotech Inc.
-20.86% 3.5B
HENAN JINDAN LACTIC ACID TECHNOLOGY CO.,LTD. Stock Henan Jindan Lactic Acid Technology Co.,Ltd.
-26.15% 384M
BIO-ON S.P.A. Stock Bio-on S.p.A.
-81.65% 216M
CHEMCON SPECIALITY CHEMICALS LIMITED Stock Chemcon Speciality Chemicals Limited
-11.06% 114M
Industrial Biotechnology Chemicals
  1. Stock Market
  2. Equities
  3. BRG Stock
  4. Financials Borregaard ASA